UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 289

Sortiert nach

Awareness and perception of accuracy of the Undetectable=Untransmittable message (U=U) in Italy: results from a survey among PLWHA, infectious-diseases physicians and people having unprotected sex

AIDS care, 2023-06, Vol.35 (6), p.923-933

2023

Link zum Volltext

Verfügbarkeit prüfen

Similar Adherence Rates Favor Different Virologic Outcomes for Patients Treated with Nonnucleoside Analogues or Protease Inhibitors

Clinical infectious diseases, 2005-01, Vol.40 (1), p.158-163

2005

Link zum Volltext

Verfügbarkeit prüfen

Rilpivirine plus cobicistat-boosted darunavir as a two-drug switch regimen in HIV-infected, virologically suppressed subjects on steady standard three-drug therapy: a randomized, controlled, non-inferiority trial (PROBE 2)

Journal of antimicrobial chemotherapy, 2020-05, Vol.75 (5), p.1332-1337

2020

Link zum Volltext

Verfügbarkeit prüfen

Efavirenz: a decade of clinical experience in the treatment of HIV

Journal of antimicrobial chemotherapy, 2009-11, Vol.64 (5), p.910-928

Maggiolo, Franco

2009

Link zum Volltext

Verfügbarkeit prüfen

Incidence and predictors of cardiovascular disease, chronic kidney disease, and diabetes in HIV/HCV-coinfected patients who achieved sustained virological response

European journal of clinical microbiology & infectious diseases, 2016-09, Vol.35 (9), p.1511-1520

2016

Link zum Volltext

Verfügbarkeit prüfen

Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy

Clinical microbiology and infection, 2012-05, Vol.18 (5), p.449-458

2012

Link zum Volltext

Verfügbarkeit prüfen

Analysis of scored goals in the cerebral palsy football World Cup

Journal of sports sciences, 2022-11, Vol.40 (22), p.2509-2516

2022

Link zum Volltext

Verfügbarkeit prüfen

FIB-4 variation in HIV/HCV co-infected patients treated with DAAs (direct-acting antivirals) with SVR12: a MaSTER cohort study

Journal of hepatology, 2017, Vol.66 (1), p.S728-S728

2017

Link zum Volltext

Verfügbarkeit prüfen

The old patient in DAA era: real life reports on 5925 patients from the Lombardy HCV Network

Journal of hepatology, 2017, Vol.66 (1), p.S536-S537

2017

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of Directly Acting Antivirals in 2432 HCV Patients with Advanced Fibrosis: An Interim Analysis of the Lombardia Regional Network for Viral Hepatitis

Journal of hepatology, 2016, Vol.64 (2), p.S213-S213

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to Italian patients in Italy: a retrospective multicentre study, 2000–2010

Infection, 2014-10, Vol.42 (5), p.859-867

2014

Link zum Volltext

Verfügbarkeit prüfen

Causes of death and risk factors among HIV-infected persons in the HAART era: analysis of a large urban cohort

Infection, 2011-02, Vol.39 (1), p.13-20

2011

Link zum Volltext

Verfügbarkeit prüfen

Treatment of chronic hepatitis C in Lombardia: An analysis on the safety and efficacy of DAA therapy in 5457 patients

Digestive and liver disease, 2017-02, Vol.49 (1), p.e70-e70

2017

Link zum Volltext

Verfügbarkeit prüfen

The old patient in DAA era: Real life reports on 5925 patients from the Lombardy HCV Network

Digestive and liver disease, 2017-02, Vol.49 (1), p.e67-e68

2017

Link zum Volltext

Verfügbarkeit prüfen

Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort

Clinical microbiology and infection, 2015-04, Vol.21 (4), p.386.e1-386.e9

2015

Link zum Volltext

Verfügbarkeit prüfen

Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis

Infection, 2012-06, Vol.40 (3), p.311-318

2012

Link zum Volltext

Verfügbarkeit prüfen

Switching from an EFV-Based STR to a RPV-Based STR is Effective, Safe and Improves HIV Patients Health Status

Value in health, 2014-11, Vol.17 (7), p.A677-A678

2014

Link zum Volltext

Verfügbarkeit prüfen

Genotype 3 infection in DAA era: Preliminary reports of a real life northern Italy network for viral hepatitis

Digestive and liver disease, 2016-10, Vol.48, p.e235-e235

2016

Link zum Volltext

Verfügbarkeit prüfen

Hyperbilirubinemia during Atazanavir Treatment in 2,404 Patients in the Italian Atazanavir Expanded Access Program and MASTER Cohorts

Infection, 2009-06, Vol.37 (3), p.244-249

2009

Link zum Volltext

Verfügbarkeit prüfen

Hyperbilirubinemia during Atazanavir Treatment in 2,404 Patients in the Italian Atazanavir Expanded Access Program and MASTER Cohorts

Infection, 2009-06, Vol.37 (3), p.244-249

2009

Link zum Volltext

Verfügbarkeit prüfen

Transplacental passage of ritonavir-boosted darunavir in two pregnant women

International journal of STD & AIDS, 2009-03, Vol.20 (3), p.215

2009

Link zum Volltext

Verfügbarkeit prüfen

Drug‐resistance development differs between HIV‐1‐infected patients failing first‐line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues

HIV medicine, 2013-10, Vol.14 (9), p.571-577

2013

Link zum Volltext

Verfügbarkeit prüfen

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

The Journal of infectious diseases, 2014-08, Vol.210 (3), p.354-362

2014

Link zum Volltext

Verfügbarkeit prüfen

Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy

Clinical microbiology and infection, 2012-03, Vol.18 (3), p.E66-E70

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 289

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(237)
Mit Volltextzugriff
(215)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(168)
Humans
(166)
Life Sciences & Biomedicine
(143)
Female
(113)
Male
(102)
Infectious Diseases
(97)
Adult
(91)
Hiv Infections - Drug Therapy
(77)
Biological And Medical Sciences
(59)
Human Immunodeficiency Virus
(59)
Medical Sciences
(59)
Middle Aged
(53)
Hiv
(46)
Pharmacology. Drug Treatments
(44)
Anti-Hiv Agents - Therapeutic Use
(43)
Microbiology
(41)
Pharmacology & Pharmacy
(39)
Hiv Infections - Virology
(38)
Immunology
(37)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(36)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Awareness and perception of accuracy of the Undetectable=Untransmittable message (U=U) in Italy: results from a survey among PLWHA, infectious-diseases physicians and people having unprotected sex

Similar Adherence Rates Favor Different Virologic Outcomes for Patients Treated with Nonnucleoside Analogues or Protease Inhibitors

Rilpivirine plus cobicistat-boosted darunavir as a two-drug switch regimen in HIV-infected, virologically suppressed subjects on steady standard three-drug therapy: a randomized, controlled, non-inferiority trial (PROBE 2)

Efavirenz: a decade of clinical experience in the treatment of HIV

Incidence and predictors of cardiovascular disease, chronic kidney disease, and diabetes in HIV/HCV-coinfected patients who achieved sustained virological response

Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy

Analysis of scored goals in the cerebral palsy football World Cup

FIB-4 variation in HIV/HCV co-infected patients treated with DAAs (direct-acting antivirals) with SVR12: a MaSTER cohort study

The old patient in DAA era: real life reports on 5925 patients from the Lombardy HCV Network

Safety and Efficacy of Directly Acting Antivirals in 2432 HCV Patients with Advanced Fibrosis: An Interim Analysis of the Lombardia Regional Network for Viral Hepatitis

Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to Italian patients in Italy: a retrospective multicentre study, 2000–2010

Causes of death and risk factors among HIV-infected persons in the HAART era: analysis of a large urban cohort

Treatment of chronic hepatitis C in Lombardia: An analysis on the safety and efficacy of DAA therapy in 5457 patients

The old patient in DAA era: Real life reports on 5925 patients from the Lombardy HCV Network

Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort

Dasabuvir and Ombitasvir/Paritaprevir/Ritonavir with or without Ribavirin in Patients with HIV-HCV Coinfection: Real Life Interim Analysis of an Italian Multicentre Compassionate Use Program

Genotypic resistance profiles associated with virological failure to darunavir-containing regimens: a cross-sectional analysis

Switching from an EFV-Based STR to a RPV-Based STR is Effective, Safe and Improves HIV Patients Health Status

Genotype 3 infection in DAA era: Preliminary reports of a real life northern Italy network for viral hepatitis

Hyperbilirubinemia during Atazanavir Treatment in 2,404 Patients in the Italian Atazanavir Expanded Access Program and MASTER Cohorts

Hyperbilirubinemia during Atazanavir Treatment in 2,404 Patients in the Italian Atazanavir Expanded Access Program and MASTER Cohorts

Transplacental passage of ritonavir-boosted darunavir in two pregnant women

Drug‐resistance development differs between HIV‐1‐infected patients failing first‐line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy

Suchergebnisse filtern